GOG-0273

Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Principal Investigator

Vivian vonGruenigen

Status

Disease Site

Gynecologic [GY] Ovarian

Phase

Other

Developmental Therapeutics

No

Primary Objective

To determine whether the score on IADL obtained prior to treatment is associated with the ability of patients to complete four cycles of chemotherapy without dose reduction or a more than 7-day delay. 

To estimate by regimen the percentage of patients who are able to complete four cycles of chemotherapy regardless of dose reductions and delays.

To compare actual and calculated carboplatin AUC in this patient population.

Patient Population

Patients who initiate one of the study chemotherapy regimens.

Target Accrual

317